Report : Europe Hematology Analyzers and Reagents Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product and Service (Hematology Products and Services, Hemostasis Products and Services, and Immunohematology Products and Services), Application (Anemia, Blood Cancer, Hemorrhagic Conditions, Infection Related Conditions, Immune System Related Conditions, and Others), End User (Hospital Laboratories, Commercial Service Providers, Government Reference Laboratories, and Research and Academic Institutes), and Country

According to a new market research study of ‘Europe Hematology Analyzers and Reagents Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by product and service, application, and end-user’ the Europe hematology analyzers and reagents market is expected to reach US$3,601.88 million in 2027 from US$ 2,037.24 million in 2019. The market is estimated to grow with a CAGR of 7.5% from 2020-2027. The report provides trends prevailing in the Europe hematology analyzers and reagents market and the factors driving market along with those that act as hindrances.

Based on product and service, the hematology analyzers and reagents market is segmented into hematology products and services, hemostasis products and services, and immunohematology products and services. The hematology products and services segment is further subdivided into instruments, reagents and consumables, and services. The hemostasis products and services segment is further subdivided into instruments, reagents and consumables, and services. The immunohematology products and services segment is further subdivided into instruments, reagents and consumables, and services.  The hematology products and services segment held the largest share of the market in 2019, also the same segment is anticipated to register the highest CAGR in the market during the forecast period. The hematology products and services market growth is expected due to increasing adoption of hematology analyzers in point-of-care settings, launch of compact and handheld devices at low and mid-budget price points and intensive competition among market players leading to constant technological development.

The growth of this market is estimated to grow owing to key driving factors such as the rising demand for organ transplantation and a high rise in organic and inorganic strategies regarding hematology analyzers and reagents. However, the market growth is likely to be hindered owing to the recalls of damaged hematology analyzers and reagents by manufacturers.

Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Danaher, BIO-RAD LABORATORIES INC. are among the leading companies operating in the Europe hematology analyzers and reagents market. 

The report segments Europe Hematology Analyzers and Reagents Market as Follows:

By Product and Service

  • Hematology Product and Services
    • Instruments
    • Reagents and Consumables
    • Services
  • Hemostasis Product and Services
    • Instruments
    • Reagents and Consumables
    • Services
  • Immunohematology Product and Services
    • Instruments
    • Reagents and Consumables
    • Services

By Application

  • Anemia
  • Blood Cancer
  • Haemorrhagic Conditions
  • Infection Related Conditions
  • Immune System Related Conditions
  • Others

By End User

  • Hospital Laboratories
  • Commercial Service Providers
  • Government Reference Laboratories
  • Research and Academic Institutes

By Country

  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
Contact Us
Contact Person: Sameer Joshi 
Phone: +1-646-491-9876
Email Id: sales@businessmarketinsights.com  

Download Free PDF Brochure